Jared S. Deyarmin

This paper identifies a stage-specific proteomic signature of Alzheimer's disease using plasma proteomics and finds a proteomic switch associated with disease progression.

The paper designs peptide inhibitors targeting fungal peptidases to reduce virulence and resistance without harming host cells, showing efficacy in vitro and in vivo.

This paper introduces a single-aliquot, enrichment-free workflow for high-throughput plasma proteome and N-glycoproteome profiling, achieving deep coverage and reproducibility in a clinical setting.

This study uses mass spectrometry to analyze proteome changes in three organs during Cryptococcus neoformans infection, identifying new immune modulatory mechanisms and antifungal targets.